-
Loading metrics
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
-
Laura V. Bownes ,
Contributed equally to this work with: Laura V. Bownes, Adele P. Williams
Roles Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
⨯ - Adele P. Williams ,
-
Raoud Marayati,
Roles Formal analysis, Investigation, Writing – review & editing
Affiliation Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
⨯ - Laura L. Stafman,
-
Hooper Markert,
Roles Formal analysis, Investigation
Affiliation Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
⨯ - Colin H. Quinn,
- Nikita Wadhwani,
- Jamie M. Aye,
- Jerry E. Stewart,
- Karina J. Yoon,
- Elizabeth Mroczek-Musulman,
- Elizabeth A. Beierle
https://orcid.org/0000-0003-3833-0657
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
- Laura V. Bownes,
- Adele P. Williams,
- Raoud Marayati,
- Laura L. Stafman,
- Hooper Markert,
- Colin H. Quinn,
- Nikita Wadhwani,
- Jamie M. Aye,
- Jerry E. Stewart,
- Karina J. Yoon
- Published: March 9, 2021
- https://doi.org/10.1371/journal.pone.0246244